Clinical trials that are rewriting the future
Preserving your cells today means preparing yourself to access the best opportunities of the future.
Ongoing Clinical Trials
At EternaCell, we closely monitor the advancements in scientific research in the field of induced pluripotent stem cells (iPSCs). With EternaCell, you will be able to generate your iPSCs for therapeutic use years after the initial sample collection. Your iPSCs will be much younger than you… Today, numerous clinical studies worldwide are demonstrating the vast potential of iPSCs for advanced therapeutic applications.
Clinical trials represent the bridge between research and medical practice, and our commitment is to ensure that our clients have access, with their own cryopreserved cells, to these technologies as soon as they become available.
Clinical Areas and Diseases Under Investigation
iPSCs, thanks to their extraordinary differentiation capacity (they can give rise to each of the over 250 cell types that make up our body), demonstrate exceptional versatility. This very characteristic makes them the subject of a large number of clinical studies in numerous medical fields.
Among the main therapeutic areas subject to clinical studies, we find:
Cardiology
With clinical studies and the first therapies approved (in Japan) to support the heart muscle after a heart attack and in heart failure.
Neurology
With clinical studies and the first approved therapies (for Parkinson’s disease in Japan) to support neural functions in Alzheimer’s disease, multiple sclerosis, and stroke.
Endocrinology
With research focused on the creation of pancreatic beta cells, essential for treating type 1 diabetes.
Oncology and Immunotherapy
With studies exploring the use of iPSCs to develop advanced therapies against various forms of cancer.
Orthopedics
With the application of iPSCs for cartilage reconstruction, bone regeneration, and the treatment of muscle injuries.
Where is the research being developed?
Every stage, from collection to freezing, is tracked, monitored, and subjected to periodic checks to ensure safety, sample integrity, and full acceptability in treatment centers around the world over time.
Specialized research in the treatment of cardiovascular diseases, with studies on post-infarction cardiac muscle regeneration.
Active in stem cell research and iPSC applications for neurology, with studies on multiple sclerosis and advanced therapies for spinal cord injuries.
Focus on personalized cell therapy, with studies aimed at creating tailored treatments for autoimmune diseases and metabolic disorders.
Strong focus on cardiology and neurodegenerative diseases, with advanced studies for the treatment of heart failure and Parkinson's disease.
Among the most advanced countries in the clinical applications of iPSCs, with ongoing trials for the restoration of pancreatic beta cells in diabetic patients and for retinal regeneration.
Numerous innovative studies on type 1 diabetes, neuronal regeneration, and cancer therapies based on iPSCs, with a particular focus on personalized treatments.
A Glimpse into the Future
Science is opening new pathways for regenerative medicine and rejuvenation, and induced pluripotent stem cells represent one of the most promising technologies of our time.
Today, the ability to cryopreserve one’s own cells offers a valuable resource for the future, enabling access to advanced, personalized therapies when needed.
At EternaCell, we believe in medicine that not only heals but regenerates, restoring health and quality of life. Keeping up with research developments means being ready today for the therapies of tomorrow, and with our service, we offer our clients the opportunity to be protagonists in this scientific revolution.
Would you like to find out about all the clinical trials currently underway?
Download our updated table of major clinical trials on iPSCs, organized by therapeutic area, development stage, and country, and stay up to date with the evolution of advanced cell therapies.